Strs Ohio Olema Pharmaceuticals, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$2.04 - $4.61 $8,160 - $18,440	-4,000 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$8.75 - $30.71 $16,625 - $58,349	1,900 Added 90.48%	4,000 $37,000
Q2 2021 Jul 26, 2021	SELL	$21.15 - $36.14 $16,920 - $28,912	-800 Reduced 27.59%	2,100 $58,000
Q1 2021 Apr 23, 2021	BUY	$27.81 - $53.64 $80,649 - $155,556	2,900 New	2,900 $96,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.